Fast Five Quiz: Dementia

Helmi L. Lutsep, MD

Disclosures

October 17, 2018

Because vascular dementia can cause symptoms and signs similar to those of DLB, brain MRI is indicated to distinguish DLB from vascular dementia. Patients with vascular dementia often have white matter lesions on MRI scans, whereas patients with DLB do not.

CSF examination is not required in routine cases. However, CSF findings in DLB include:

  • Patients with Alzheimer disease have higher levels of tau protein in their CSF than do patients with DLB

  • Patients with the Lewy body variant of Alzheimer disease (LBV-AD) have intermediate values

  • CSF levels of beta amyloid are lower than normal in DLB, Alzheimer disease, and LBV-AD; however, CSF beta-amyloid levels in DLB, LBV-AD, and Alzheimer disease do not differ from each other

Patients with DLB usually have less hippocampal atrophy than do patients with Alzheimer disease (but more than control subjects), although whether this difference is clinically useful is under investigation, as is the diagnostic utility of functional imaging. MRI is superior to CT scanning in identifying this atrophy.

Until disease-modifying therapies that are specific to DLB or Alzheimer disease are developed, metabolic imaging studies to enhance the accuracy of the diagnosis are rarely needed.

For more on the workup of DLB, read here.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....